Physician profile
Derek King
NPI 1295129401
$3,332.29
in general payments reported to CMS, 2019-2025
10 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.02 · 2020: $296 · 2021: $2,241 · 2022: $460 · 2023: $81.81 · 2024: $109 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,197.28 | 2021-2022 | |
| Relievant Medsystems, INC. | $1,043.23 | 2021 | |
| Boston Scientific Corporation | $370.01 | 2020-2024 | Spyglass, Resolution 360 Ultra Clip, Compliance Endokit |
| Nevro Corp. | $288.17 | 2020-2021 | |
| Avanos Medical | $219.41 | 2019-2022 | |
| Medtronic, INC. | $85.73 | 2021 | |
| Merck Sharp & Dohme LLC | $55.00 | 2024-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $36.64 | 2025 | Exparel |
| Cumberland Pharmaceuticals, INC. | $22.78 | 2025 | Caldolor |
| Fisher & Paykel Healthcare INC | $14.04 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.